Barlow, J, Jarrett, P, Mockford, C, McIntosh, E, Davis, H, and Stewart-Brown, S (2006). The role of home visiting in improving parenting and health in families at risk of abuse and neglect: Results of a multicentre randomised controlled trial and economic evaluation. Arch Dis Child.

Bioethics Working Party, NCo (2006). Critical care decisions in fetal and neonatal medicine: Ethical issues. Nuffield Council on Bioethics, Nuffield Council on Bioethics Working Party (S.Petrou member of working Party), London.

Bollapragada, S, Mackenzie, F, Norrie, J, Petrou, S, Reid, M, Greer, I, Osman, I, and Norman, JE (2006). IMOP: randomised placebo controlled trial of outpatient cervical ripening with isosorbide mononitrate (IMN) prior to induction of labour - clinical trial with analyses of efficacy, cost effectiveness and acceptability. BMC Pregnancy Childbirth, 6:25.

Briggs, A, Mihaylova, B, Sculpher, M, Hall, A, Wolstenholme, J, Simoons, M, Deckers, J, Roberto, F, Remme, WJ, Bertrand, M, and Fox, K (2006). The Cost-effectiveness of perindopril in reducing cardiovascular events in patients with stable coronary artery disease using data from the EUROPA Study. Heart.

Campbell, H, Rivero-Arias, O, Johnston, K, Gray, A, Fairbank, J, and Frost, H (2006). Responsiveness of objective, disease-specific, and generic outcome measures in patients with chronic low back pain: an assessment for improving, stable, and deteriorating patients. Spine, 31(7):815-22.

Clarke, P, Kelman, C, and Colagiuri, S (2006). Factors influencing the cost of hospital care for people with diabetes in Australia. J Diabetes Complications, 20(6):349-55.

Clarke, PM and Ryan, C (2006). Self-reported health: reliability and consequences for health inequality measurement. Health Econ, 15(6):645-52.

Clarke, PM, Simon, J, Cull, CA, and Holman, RR (2006). Assessing the impact of visual acuity on quality of life in individuals with type 2 diabetes using the short form-36. Diabetes Care, 29(7):1506-11.

Edwards, SJ, Campbell, HE, and Plumb, JM (2006). Cost-utility analysis comparing meropenem with imipenem plus cilastatin in the treatment of severe infections in intensive care. Eur J Health Econ, 7(1):72-8.

Gray, AM (2006). Cost-effectiveness analyses alongside randomised clinical trials. Clin Trials, 3(6):538-42.

Gray, AM, Rivero-Arias, O, and Clarke, PM (2006). Estimating the association between SF-12 responses and EQ-5D utility values by response mapping. Med Decis Making, 26(1):18-29.

Henderson, J and Petrou, S (2006). The economic case for planned cesarean section for breech presentation at term. CMAJ, 174(8):1118-9.

Hutchinson, J, Lloyd, A, Gray, A, Gale, R, and Hancock, B (2006). Costs of chemotherapy for indolent follicular non-Hodgkin's lymphoma in the UK: an observational study. Acta Haematol, 115(1-2):28-34.

Kendrick, T, Simons, L, Mynors-Wallis, L, Gray, A, Lathlean, J, Pickering, R, Harris, S, Rivero-Arias, O, Gerard, K, and Thompson, C (2006). Cost-effectiveness of referral for generic care or problem-solving treatment from community mental health nurses, compared with usual general practitioner care for common mental disorders: Randomised controlled trial. Br J Psychiatry, 189:50-9.

Kennedy, CR, McCann, DC, Campbell, MJ, Law, CM, Mullee, M, Petrou, S, Watkin, P, Worsfold, S, Yuen, HM, and Stevenson, J (2006). Language ability after early detection of permanent childhood hearing impairment. N Engl J Med, 354(20):2131-41.

Leal, J, Luengo-Fernandez, R, Gray, A, Petersen, S, and Rayner, M (2006). Economic burden of cardiovascular diseases in the enlarged European Union. Eur Heart J, 27(13):1610-9.

Leal, J, Wordsworth, S, Gray, A, Oerton, J, Philips, P, and Dezateux, D (2006). Policy making for rare childhood diseases. Eur J Health Econ, 7(1):S58.

Legood, R, Gray, A, Wolstenholme, J, and Moss, S (2006). Lifetime effects, costs, and cost effectiveness of testing for human papillomavirus to manage low grade cytological abnormalities: results of the NHS pilot studies. BMJ, 332(7533):79-85.

Luengo-Fernandez, R, Gray, AM, and Rothwell, PM (2006). Population-based study of determinants of initial secondary care costs of acute stroke in the United Kingdom. Stroke, 37(10):2579-87.

Luengo-Fernandez, R, Leal, J, Gray, A, Petersen, S, and Rayner, M (2006). Cost of cardiovascular diseases in the United Kingdom. Heart, 92(10):1384-9.